Alka Batycky Batycky
Bio
P’27
Over her 25 year career in global drug development, Alka has advanced life-changing products, from early drug discovery through regulatory approvals, covering a range of therapeutic areas including addiction, cancer, diabetes, Duchenne’s muscular dystrophy, rheumatoid arthritis, asthma, and inflammatory bowel diseases. She currently sits on the Board of Directors for Landos Biopharmaceuticals and works with other private startups. She is a strong advocate for STEM, women in science, and having a critical mind to understand and appreciate the world around us.